LSD的第一个临床研究和在身患绝症的病人方面的研究超过了35年了,预计会在这个夏季结束。
Peter Gasser, the Swiss doctor leading the experiment, says that a combination of LSD andpsychotherapy reduced anxiety levels of all 12 participants in the study, though thestatistical significance of the data has yet to be analysed.
领导这个实验的瑞士医生彼得?加塞说LSD和心理治疗的结合缓解了12名参与者的焦虑程度,虽然该实验的统计意义还有待于分析。
Research into LSD is not confined to medicine.
对于LSD的研究并不局限于药物方面。
Franz Vollenweider, of the Heffter Research Institute in Zurich, for example, is scanningpeople s brains to try to understand how hallucinogenic drugs cause changes inconsciousness.
例如,海弗特研究学会的弗朗茨?沃尔温德正在扫描人的大脑,试图搞清楚迷幻药如何引起意识的变化。
And biotechnology may lead to a new generation of hallucinogenic drugs.
生物技术也可能会导致新一代迷幻药物的出现。
Edwin Wintermute and his colleagues at Harvard have engineered yeast cells to carry outtwo of six steps in the pathway needed to make lysergic acid, the precursor of LSD.
埃德温?温特姆特和他在哈佛的同事已经通过基因工程改造了酵母细胞,在产生麦角酸LSD的前体的六步反应路径中已经实现了其中的两步。
【2015考研英语阅读迷幻药之考验】相关文章:
最新
2016-10-18
2016-10-11
2016-10-11
2016-10-08
2016-09-30
2016-09-30